| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 08/03/2010 | US7767450 Nucleotide sequences coding voltage-gated transport proteins for use as screening tools to identify modulators for treatment and prevention of nervous, muscular, glandular, immune, reproductive and epithelial tissue disorders |
| 08/03/2010 | US7767392 Nucleotide sequences coding zinc finger protein for use in identifying modulators of cell proliferation disorders; antitumor agents |
| 08/03/2010 | US7767232 Control of nitric oxide bioactivity by perfluorocarbons |
| 08/03/2010 | US7767223 Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use |
| 08/03/2010 | US7767216 Antimicrobial compositions and methods of use |
| 08/03/2010 | US7767207 Interleukin-18 specific immunoglobulins for treatment and prevention of autoimmune, respiratory, reproductive, heart, connective tissue, liver, bone and arthritic disorders |
| 08/03/2010 | CA2528622C Combination of an nmda receptor antagonist and a selective serotonin reuptake inhibitor for the treatment of depression and other mood disorders |
| 08/03/2010 | CA2492724C The use of epidermal growth factor as a gastrointestinal therapeutic agent |
| 08/03/2010 | CA2490191C Modified 2' and 3' -nucleoside prodrugs for treating flaviviridae infections |
| 08/03/2010 | CA2480080C Composition for cell proliferation |
| 08/03/2010 | CA2444269C Treatment of disorders secondary to organic impairments |
| 08/03/2010 | CA2430091C An antibiotic/analgesic formulation and a method of making this formulation |
| 08/03/2010 | CA2386325C Gallium complexes of 3-hydroxy-4-pyrones to treat infection by intracellular prokaryotes, dna viruses and retroviruses |
| 08/03/2010 | CA2382223C Fat or oil composition |
| 08/03/2010 | CA2381047C Vaccine against hepatitis b virus and human papilloma virus |
| 08/03/2010 | CA2361949C Heparin, or heparin conjugate, islets of langerhans |
| 08/03/2010 | CA2294101C A combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor |
| 08/03/2010 | CA2265853C Inhibition of apoptosis using interleukin-1.beta.-converting enzyme (ice)/ced-3 family inhibitors |
| 07/29/2010 | WO2010085753A1 Rosacea treatments and kits for performing them |
| 07/29/2010 | WO2010085462A1 Method for treating triple negative breast cancer |
| 07/29/2010 | WO2010084999A1 Immunosuppressive agents and prophylactic and therapeutic agents for autoimmune diseases |
| 07/29/2010 | WO2010084668A1 Diagnostic method for nephrotic syndrome, prophylactic or therapeutic agent for nephrotic syndrome, and method for screening the prophylactic or therapeutic agent |
| 07/29/2010 | WO2010084500A1 New combination of active ingredients containing a non steroidal anti inflammatory drug and a colchicoside derivative |
| 07/29/2010 | WO2010084188A1 Delayed-release glucocorticoid treatment of asthma |
| 07/29/2010 | WO2010084134A1 Phd2 inhibition for blood vessel normalization, and uses thereof |
| 07/29/2010 | WO2010083975A1 Combinations comprising methotrexate and dhodh inhibitors |
| 07/29/2010 | WO2010041140A3 Treatment of proliferative disorders with a death receptor agonist |
| 07/29/2010 | WO2010018549A3 Therapeutic compositions containing macitentan |
| 07/29/2010 | US20100190964 Antibodies to human ErbB4 |
| 07/29/2010 | US20100190838 Connective Tissue Growth Factor Fragments and Methods and Uses Thereof |
| 07/29/2010 | US20100190738 Use of Aalkylphophocholines in Combination with Antitumor Medication for the Treatment of Benign and Melignant Oncoses in Humans and Mammals |
| 07/29/2010 | US20100189784 Use of Alkylphophocholine in Combination with Antitumor Medication for the Treatment of Benign and Malignant Oncoses in Humans and Mammals |
| 07/29/2010 | US20100189720 Novel card proteins involved in cell death regulation |
| 07/29/2010 | US20100189702 Compositions and methods for restoring bacterial flora |
| 07/29/2010 | US20100189684 USE OF gp130 ACTIVATORS IN DIABETIC NEUROPATHY |
| 07/29/2010 | US20100189649 Monoclonal antibodies to activated erbb family members and methods of use |
| 07/29/2010 | CA2750457A1 New combination of active ingredients containing a non steroidal anti inflammatory drug and a colchicoside derivative |
| 07/29/2010 | CA2750044A1 Phd2 inhibition for blood vessel normalization, and uses thereof |
| 07/29/2010 | CA2749646A1 Delayed-release glucocorticoid treatment of asthma |
| 07/29/2010 | CA2748400A1 Combinations comprising methotrexate and dhodh inhibitors |
| 07/28/2010 | EP2210643A2 Combinations comprising epothilones and pharmaceutical uses thereof |
| 07/28/2010 | EP2210615A1 Combinations comprising methotrexate and DHODH inhibitors |
| 07/28/2010 | EP2210614A1 Combinations comprising antimuscarinic agents and PDE4 inhibitors |
| 07/28/2010 | EP2210613A1 Combinations comprising antimuscarinic agents and PDE4 inhibitors |
| 07/28/2010 | EP2210606A2 Methods Of Using And Compositions Comprising Immunomodulatory Compounds For The Treatment And Management Of Myeloproliferative Diseases |
| 07/28/2010 | EP2210602A1 Compositions for the treatment of symptoms associated with respiratory inflammations |
| 07/28/2010 | EP2210587A1 Production process for NSAID-containing lozenges, their compositions, their medicinal use |
| 07/28/2010 | EP2209801A2 Manufacture, compositions and uses of coagulationfactor viia modulator |
| 07/28/2010 | EP2209371A1 Compositions and methods for treatment of diabetic retinopathy |
| 07/28/2010 | EP1487856B1 Human antibodies specific to kdr and uses thereof |
| 07/28/2010 | EP1458392B9 Acridones as inhibitors of impdh enzyme |
| 07/28/2010 | EP1432403B1 Liposome loading with metal ions |
| 07/28/2010 | EP1315831B1 Stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents |
| 07/28/2010 | EP1250135B1 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders |
| 07/28/2010 | CN1974596B 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 07/28/2010 | CN1972679B Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and AT1-receptor antagonists |
| 07/28/2010 | CN1767819B Solid pharmaceutical compositions comprising a S1P receptor agonist and a sugar alcohol |
| 07/28/2010 | CN101790539A Amelioration of cellular stress response |
| 07/28/2010 | CN101787072A Specific binding agents of human angiopoietin-2 |
| 07/28/2010 | CN101785865A pH response type amphipathic stem-grafting polyphosphazenes feeding micelle and preparation method thereof |
| 07/28/2010 | CN101785859A Antidepressant medicament combination preparation, application method and application |
| 07/28/2010 | CN101785858A Medicine combination containing isosorbide mononitrate for treating high blood pressure |
| 07/28/2010 | CN101785772A Methods for treating or preventing vascular inflammation using sterol absorption inhibitor(s) |
| 07/28/2010 | CN101199480B Compounded propofol fat emulsion injection containing analgesics and process for preparing same |
| 07/27/2010 | US7763641 such as [(1S,2R)-2-hydroxy-3-[N-[4-(2-methylaminothiazol-4-yl)phenylsulfonyl]-N-(2-methylpropyl)amino]-1-(phenylmethyl)propyl]carbamic acid, [(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl]ester, used for treating human immunodeficiency virus infections |
| 07/27/2010 | US7763631 substituted amino pyrimidine derivatives useful in the treatment or prevention of viral infections, in particular against human immunodeficiency virus (HIV), which is the aetiological agent of acquired immune deficiency syndrome (AIDS) in humans |
| 07/27/2010 | US7763610 cysteinyl leukotriene antagonists such as 4-(3-carboxypropyl)-8-((4-(4-phenylbutoxy)benzoyl)amino)-3,4-dihydro-2H-1,4-benzoxazine-2-carboxylic acid, used for treating asthma, chronic obstructive pulmonary disease, pneumonia, rhinitis and as expectorants or antitussives |
| 07/27/2010 | US7763580 In a tissue, organ or wound site using a synergistic mixture of transforming growth factor beta inhibitors and agents that degrade the excess accumulated extracellular matrix; fibrotic diseases and scarring |
| 07/27/2010 | US7763435 Method for diagnosis of alzheimer's disease with determination of LASP-1 immunoreactivity |
| 07/27/2010 | US7763422 evaluating the amount of cancer cells existing in pancreatic cells or tissues, by measuring the methylation frequency of Fibrillin2 gene or an index value having the correlation therewith, and comparing with a control; medical diagnosis |
| 07/27/2010 | US7763278 As cholesterol lowering agents and for treatment of cardiovascular disorders |
| 07/27/2010 | US7763255 Therapeutic uses of Dunaliella powder |
| 07/27/2010 | US7763252 Methods of identifying susceptibility of cells to reovirus infection by measuring constitutive ras-MAP signaling; using reovirus for treatment of cellular proliferative disorders, particularly wherein proliferating cells exhibit constitutive MAPK phosphorylation in mammals; antitumor agents |
| 07/27/2010 | CA2481241C Fused quinoxaline derivatives as inhibitors of akt activity |
| 07/27/2010 | CA2436659C Cannabinoid receptor ligands |
| 07/27/2010 | CA2404000C A functional assay of high-density lipoprotein |
| 07/27/2010 | CA2384717C Topical treatment for prevention of ocular infections |
| 07/27/2010 | CA2375820C The myostatin gene promoter and inhibition of activation thereof |
| 07/22/2010 | WO2010082821A1 Method of treating cancer |
| 07/22/2010 | WO2010082813A1 Method of treating cancer |
| 07/22/2010 | WO2010082182A1 Fulvic acid in combination with fluconazole or amphotericin b for the treatment of fungal infections |
| 07/22/2010 | WO2010081862A2 Methods and preparations for protecting critically ill patients |
| 07/22/2010 | WO2010081825A2 Pirenzepine as an agent in cancer treatment |
| 07/22/2010 | WO2010081823A1 Pirenzepine as otoprotective agent |
| 07/22/2010 | WO2010081662A2 Methods for identifying patients who will respond well to cancer treatment |
| 07/22/2010 | WO2010081647A2 Sgc stimulators of sgc activators in combination with pde5 inhbitors for the treatment of erectile dysfunction |
| 07/22/2010 | WO2010048731A8 Aminoacyl trna-synthetase inhibitors as broad-spectrum immunosuppressive agents |
| 07/22/2010 | US20100184797 Treatment of dyskinesia |
| 07/22/2010 | US20100184784 Pharmaceutical compositions comprising a multifunctional phosphodiesterase inhibitor and an adenosine uptake inhibitor |
| 07/22/2010 | US20100184743 Use of cholinesterase inhibitors for treating vascular depression |
| 07/22/2010 | US20100184725 Method and Composition for Treating Alzheimer's Disease and Dementias of Vascular Origin |
| 07/22/2010 | US20100184690 Combined Use Of A GLP-1 Compound And A Modulator Of Diabetic Late Complications |
| 07/22/2010 | US20100184686 Use of inhibitors for the treatment of rtk-hyperfunction-induced disorders, particularly cancer |
| 07/22/2010 | US20100183685 Tumor and infectious disease therapeutic compositions |
| 07/22/2010 | US20100183677 Fusion proteins of mycobacterium tuberculosis |
| 07/22/2010 | US20100183581 Compositions and Methods for Modulating Blood-Brain Barrier Transport |
| 07/22/2010 | US20100183562 Sub -population of hematopoietic stem cells that express the crisp-1 protein |
| 07/22/2010 | US20100183560 Angiogenesis-modulating compositions and uses |
| 07/22/2010 | US20100183548 Tweak receptor |
| 07/22/2010 | CA2749424A1 Method of treating cancer |